Kitov Pharmaceuticals Holdings Ltd. reported audited consolidated earnings results for the year ended December 31, 2016. For the year, the company reported operating loss of $7,183,000 compared to $4,069,000 a year ago. Loss for the year was $12,125,000 compared to $4,202,000 a year ago. Basic and diluted loss per share was $0.11 compared to $0.22 a year ago. Net cash used in operating activities was $1,072,000 compared to $574,000 a year ago. Net cash used in operating activities was $6,262,000 compared to $3,308,000 a year ago. Acquisition of fixed assets were $10,000 compared to $9,000 a year ago.